0001104659-22-130251.txt : 20221227 0001104659-22-130251.hdr.sgml : 20221227 20221227185002 ACCESSION NUMBER: 0001104659-22-130251 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211121 FILED AS OF DATE: 20221227 DATE AS OF CHANGE: 20221227 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Poll Claire CENTRAL INDEX KEY: 0001836820 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38067 FILM NUMBER: 221491396 MAIL ADDRESS: STREET 1: C/O VERONA PHARMA PLC STREET 2: 3 MORE LONDON RIVERSIDE CITY: LONDON STATE: X0 ZIP: SE1 2RE ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Verona Pharma plc CENTRAL INDEX KEY: 0001657312 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 MORE LONDON RIVERSIDE CITY: LONDON STATE: X0 ZIP: SE1 2RE BUSINESS PHONE: 011-44-0-2032834200 MAIL ADDRESS: STREET 1: 3 MORE LONDON RIVERSIDE CITY: LONDON STATE: X0 ZIP: SE1 2RE 4 1 tm2233427-1_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2021-11-21 0 0001657312 Verona Pharma plc VRNA 0001836820 Poll Claire 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE UNITED KINGDOM 0 1 0 0 General Counsel Ordinary Shares 2021-11-21 4 G 0 90104 0 D 2472951 D Ordinary Shares 2021-11-21 4 G 0 90104 0 A 573944 I By Trust Ordinary Shares 2022-02-22 5 G 0 E 90104 0 D 2382847 D Ordinary Shares 2022-02-22 5 G 0 E 90104 0 A 664048 I By Trust Ordinary Shares 2022-05-22 5 G 0 E 90104 0 D 2292743 D Ordinary Shares 2022-05-22 5 G 0 E 90104 0 A 754152 I By Trust Ordinary Shares 2022-08-21 5 G 0 E 90104 0 D 2202639 D Ordinary Shares 2022-08-21 5 G 0 E 90104 0 A 844256 I By Trust Ordinary Shares 2022-11-22 5 G 0 E 170000 0 D 2032639 D Ordinary Shares 2022-11-22 5 G 0 E 170000 0 A 1014256 I By Trust Ordinary Shares 2022-12-22 4 S 0 240000 2.6918 D 774256 I By Trust Reported securities are represented by American Depositary Shares ("ADSs") (unless otherwise indicated), each of which represents eight (8) Ordinary Shares of the Issuer. Held by a family trust of which (a) the Reporting Person and spouse are trustees and (b) the Reporting Person and members of her immediate family are the sole beneficiaries of the trust. Consists of (i) 1,990,000 Ordinary Shares underlying Restricted Share Units (each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer) (which may be represented by 248,750 ADSs); (ii) 42,632 Ordinary Shares underlying 5,329 ADSs; and (iii) 7 Ordinary Shares. The price reported represents the weighted average sale price of the ADSs divided by eight (8). These shares were sold in multiple transactions at prices ranging from $2.675 to $2.7138, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. /s/ Claire Poll 2022-12-27